Escolar Documentos
Profissional Documentos
Cultura Documentos
Immune-Mediated Neuropathy
Characterized clinically by weakness : prox distal
(ascending paralysis)
Histology : inflammation and demyelination of
spinal nerve roots and peripheral nerves
(radiculoneuropathy)
Guillain-Barr Syndrome
(Acute Inflammatory Demyelinating Polyradiculoneuropathy)
Pathogenesis
Preceding infection : Campylobacter jejuni,
cytomegalovirus, Epstein-Barr virus, and
Mycoplasma pneumoniae
The infection induce T cell-mediated immune
response segmental demyelination induced by
activated macrophages
Lymphocytes from patients with Guillain-Barr
syndrome can produce demyelination in tissue
cultures of myelinated nerve fibers
Guillain-Barr Syndrome
(Acute Inflammatory Demyelinating Polyradiculoneuropathy)
Morphology :
Inflammation of peripheral nerve
Perivenular and endoneurial infiltration by lymphocytes,
macrophages, and plasma cells
Segmental demyelination
Damage of axon
INFECTIOUS POLYNEUROPATHIES
Leprosy
Lepromatous leprosy
Mycobacterium leprae invade Schwann cells and other
cells.
Segmental demyelination and remyelination
Loss of both myelinated and unmyelinated axons.
Endoneurial fibrosis and multilayered thickening of the
perineurial sheaths
Symmetric polyneuropathy that prominently involves pain
fibers; the resulting loss of sensation contributes to injury
INFECTIOUS POLYNEUROPATHIES
Leprosy
Tuberculoid leprosy
Cell-mediated immune response to M. leprae
Nodular granulomatous inflammation in the dermis
The inflammation injures cutaneous nerves ; axons,
Schwann cells, and myelin are lost
Fibrosis of the perineurium and endoneurium
INFECTIOUS POLYNEUROPATHIES
Varicella-Zoster Virus
Latent infection of neurons in the sensory ganglia of the
spinal cord and brain stem
Reactivation The virus may be transported along the
sensory nerves to the skin painful, vesicular skin
eruption in the distribution of sensory dermatomes
(shingles)
Affected ganglia show neuronal destruction, mononuclear
inflammatory infiltrates
Peripheral nerve shows axonal degeneration
Focal destruction of the large motor neurons of the
anterior horns or cranial nerve motor nuclei
HEREDITARY NEUROPATHIES
Hereditary motor and sensory neuropathies (HMSN)
sensorimotor neuropathies
mutations in genes whose products are involved in the
formation and maintenance of myelin
Hereditary sensory and autonomic neuropathies
(HSAN)
symptoms : numbness, pain, and autonomic
dysfunction such as orthostatic hypotension
Familial amyloid polyneuropathies (FAP)
mutations of the transthyretin gene involved in
transport of thyroid hormone
deposition of amyloid within the peripheral nervous
system
TABLE 27-2 -- Hereditary Sensory and Autonomic Neuropathies (HSANs)
Disease and Inheritance Gene and Locus Clinical and Pathologic Findings
HSAN I; autosomal dominant Serine palmitoyl transferase, long- Predominantly sensory neuropathy,
chain base, subunit 1 (SPTLC1) presenting in young adults; axonal
gene; 9q22.1q22.3 degeneration (mostly myelinated
fibers)
HSAN II; autosomal recessive HSN2 gene; 12q13.3 Predominantly sensory neuropathy,
(some cases are sporadic) presenting in childhood; axonal
degeneration (mostly myelinated
fibers)
HSAN III; (Riley-Day syndrome; IKAP histone acetyltransferase Predominantly autonomic
familial dysautonomia; most often (IKAP) gene; 9q31 neuropathy, presenting in infancy;
in Jewish children); autosomal axonal degeneration (mostly
recessive unmyelinated fibers); atrophy and
loss of sensory and autonomic
ganglion cells
HSAN IV; autosomal recessive Neurotrophic tyrosine kinase Congenital insensitivity to pain and
dysautonomia, type II; receptor, type 1, or NTRK1 gene; anhidrosis; presentation in infancy;
1q21q22 nearly complete loss of small
myelinated and unmyelinated fibers
HSAN V; autosomal recessive Nerve growth factor subunit Congenital insensitivity to pain and
(NGFB) gene; 1p13.1 temperature; presentation in infancy;
nearly complete loss of small
myelinated fibers
METABOLIC AND TOXIC NEUROPATHIES
Toxic Neuropathies
Peripheral neuropathies caused by industrial or
environmental chemicals, biologic toxins, or therapeutic
drugs.
Morphology :
large numbers of atrophic fibers, often involves an entire
fascicle
(panfascicular atrophy)
Spinal muscular atrophy with groups of atrophic
muscle fibers resulting from denervation atrophy of
muscle in early childhood.
MUSCULAR DYSTROPHIES
X-Linked Muscular Dystrophy (Duchenne Muscular
Dystrophy and Becker Muscular Dystrophy)
Clinical Course
Weakness begins in the pelvic girdle muscles and then
extends to the shoulder girdle
Enlargement of the calf muscles (pseudohypertrophy)
Patients may develop heart failure or arrhythmias
Serum creatine kinase is elevated during the first decade
of life
Death results from respiratory insufficiency, pulmonary
infection, and cardiac decompensation
ION CHANNEL MYOPATHIES (CHANNELOPATHIES)
Clinical features :
myotonia (sustained involuntary muscles contraction)
hypotonic paralysis induced by :
exercise, cold, or a high-carbohydrate meal
depand on Potassium level : hyperkalemic, hypokalemic,
and normokalemic periodic paralysis
Caused by mutations in genes that encode ion channels
Hyperkalemic periodic paralysis : mutations in the gene
for muscle sodium channel protein (SCN4A)
Hypokalemic periodic paralysis : mutations in gene for
voltage-gated calcium channel
MYOPATHIES ASSOCIATED WITH INBORN ERRORS OF
METABOLISM
Lipid Myopathies
Steps in lipid oxidation :
1. acyl-CoA transesterified with carnitine by outer
membrane carnitine palmitoyltransferase (CPT I)
2. transported across the inner mitochondrial
membrane
3. re-esterified to acyl-CoA esters by an inner
membrane mitochondrial CPT II
4. catabolized to acetyl-CoA units by the acyl-CoA
dehydrogenases